DxCover
Developing a spectroscopic liquid biopsy for rapid detection of cancer.
Launch date
Employees
Market cap
-
Enterprise valuation
AUD61—92m (Dealroom.co estimates Feb 2023.)
Company register number SC535447
Glasgow Scotland (HQ)
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
* | N/A | Spinout | |
N/A | Grant | ||
£1.2m | Seed | ||
N/A | Support Program | ||
£2.4m | Seed | ||
£1.1m Valuation: £12.0m | Seed | ||
* | €2.5m | Grant | |
* | £7.5m | Series A | |
Total Funding | AUD29.1m |
Related Content
Recent News about DxCover
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.